目的 探讨Ｃ反应蛋白(CRP)在慢性阻塞性肺疾病急性加重期(AECOPD)患者治疗前、后的变化和临床意义。方法 纳入2008年1月-9月住院治疗的80例AECOPD患者，分别测定应用抗生素治疗前后CRP、白细胞计数(WBC)、中性粒细胞百分比(N%)、血沉和体温，并比较这些指标的变化情况。结果 AECOPD患者在感染期CRP总阳性率为100.00%，显著高于治疗前WBC、N%、血沉和体温的阳性率(Plt;0.05)；也显著高于感染控制后(Plt;0.05)。 结论 CRP作为细菌性感染的敏感指标之一，也可作为指导临床及时、正确使用或评价抗生素疗效的一个指标。
【摘要】 目的 分析护理干预对纤维支气管镜检查患者的心理影响。方法 2008年1月—12月，通过对100例患者的问卷调查及临床观察,总结分析其心理特点及所采取的护理干预措施的影响。结果 纤维支气管镜检查患者的心理特点有:恐惧心理、紧张心理、消极心理等；相应的护理干预:教育性干预、行为训练、情感支持、药物干预等。结论 正确评估患者的心理特点,采取有效的护理干预,改善患者的心理状况,有利于提高患者的依从性,从而提高检查的成功率。【摘要】 目的 分析护理干预对纤维支气管镜检查患者的心理影响。方法 2008年1月—12月，通过对100例患者的问卷调查及临床观察,总结分析其心理特点及所采取的护理干预措施的影响。结果 纤维支气管镜检查患者的心理特点有:恐惧心理、紧张心理、消极心理等；相应的护理干预:教育性干预、行为训练、情感支持、药物干预等。结论 正确评估患者的心理特点,采取有效的护理干预,改善患者的心理状况,有利于提高患者的依从性,从而提高检查的成功率。
ObjectiveTo explore the application of tracking method in intravenous treatment in primary hospitals, in order to improve the quality of nursing of intravenous therapy. MethodsFor the 22 events of venous transfusion adverse reactions between January and March 2013, we used tracking methodology for tracking and analyzing the reasons. Through this, we regulated and implemented specific improvement scheme, perfected rules and regulations to improve the work process. ResultsThrough reason analysis and improving regulations, the number of intravenous infusion adverse reactions was decreased from 22 in the first quarter to 0 in the fourth quarter of the year. ConclusionTracking methodology used for regulating the intravenous treatment behaviors of basic-level hospitals nurses can reduce the occurrence of adverse transfusion reaction
Objective To investigate perindopiI influence for the complication in hypertensive patients with stroke history by lowering blood pressure. Methods One-hundred and fifty-five essential hypertensive patients with stroke history were randomly assigned to either perindopril group or placebo group, receiving a randomized, double-blind, placebo-controlled trial as long as 3 years. Their blood pressure, the morbidity and mortality of cardiocerebral complications were monitored. At the end of trial, three days Ambulatory Blood Pressure Monitoring were performed. Result It was shown that in perindopril group blood pressure was controlled satisfactorily, and the morbidity and mortality of cardiocerebral incidences (6.85 % and 2.74 %repectively) were lower than those of placebo group (17.10% and 9.21% respectively). Conclusions Perindopril lowers blood pressure effectively and persistently. It has important clinical effect for prevention the cardiocerebral complications in hypertensive patients with stroke history by lowering blood pressure.